 - Relapsed or refractory multiple myeloma defined as: Failure of at least 2 previous therapies including an immunomodulatory agent thalidomide or lenalidomide and a proteasome inhibitor unless the subjects were not eligible or refused to receive those treatments, and with progressive disease, defined by an increase of serological or urine myeloma parameters by 25 to the last value 